Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

68 filings reported holding MAZE - Maze Therapeutics, Inc. - Common Stock, par value $0.001 as of Q1 2025.
Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40M shares of 43.5M outstanding shares and own 92.05% of the company stock.
Largest 10 shareholders include TRV GP IV, LLC (6.07M shares), Frazier Life Sciences Management, L.P. (4.13M shares), ARCH Venture Management, LLC (4.12M shares), Deep Track Capital, LP (3.27M shares), Matrix Capital Management Company, LP (2.49M shares), Alphabet Inc. (2.41M shares), Foresite Capital Management IV, LLC (2.11M shares), AH CAPITAL MANAGEMENT, L.L.C. (1.7M shares), JANUS HENDERSON GROUP PLC (1.25M shares), and General Catalyst Group Management, LLC (1.04M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.